Skip to main content
. 2016 Nov 30;9:1131–1141. doi: 10.2147/JPR.S119845

Table 2.

Prevalence of comorbidities and medications (prescribed and non-prescribed) in the total sample, in the different pain categories, and comparisons among them

Variables (n, %) Total sample
(n=6611)
NP (n=3227) LP (n=1585) RP-Medium
(n=1344)
RP-Heavy
(n=341)
WSP
(n=114)
Differences among pain categories
(p-value)
Comorbidities
 Traumatic injuries 636 (10.8) 158 (5.2) 165(11.6) 215 (19.2) 71 (24.1) 27 (23.1) <0.001
 Rheumatoid arthritis and osteoarthritis 2165 (37.0) 474 (16.0) 587 (42.4) 772 (66.0) 240 (79.0) 92 (87.8) <0.001
 Cardiovascular disorders 3319 (53.8) 1502 (50.0) 791(53.8) 745 (58.8) 209 (66.1) 72 (63.7) <0.001
 Pulmonary disorders 879 (14.5) 332 (11.2) 194(13.3) 241 (19.5) 83 (27.8) 29 (27.9) <0.001
 Depressive disorders 789 (13.6) 277 (9.5) 196 (13.8) 221 (19.7) 64 (21.8) 31 (31.9) <0.001
 Anxiety disorders 995 (16.7) 355 (11.9) 229 (16.0) 279 (23.8) 84 (27.8) 48(47.1) <0.001
 Gastrointestinal disorders 1255 (20.9) 363 (12.1) 327 (22.8) 383 (32.0) 132 (42.7) 50 (46.6) <0.001
 Disorders of CNS 2524 (39.5) 1040 (33.0) 614 (40.6) 627 (48.0) 180 (55.5) 63 (60.8) <0.001
 Urogenital disorders 651 (10.1) 236 (7.4) 167 (11.1) 163 (12.2) 61 (19.2) 24 (22.1) <0.001
 Skin disorders 712 (11.8) 257 (9.3) 185 (12.5) 172 (14.0) 61 (19.9) 19 (19.4) <0.001
 Tumors and cancer 505 (8.1) 215 (7.0) 127 (8.5) 116 (9.3) 38 (12.5) 9 (8.6) 0.007
 Metabolic disorders 1059 (17.0) 423 (13.9) 247 (16.2) 270 (21.5) 85 (27.8) 34 (31.8) <0.001
Prescribed medication
 Analgesics 1031 (15.7) 149 (4.5) 272 (17.0) 391 (29.4) 149 (44.0) 70 (63.0) <0.001
 Gastroesophageal reflux medication 537 (8.7) 156 (5.1) 124 (8.2) 178 (14.2) 57 (17.7) 22 (22.4) <0.001
 Constipation medication 364 (5.8) 121 (3.9) 75 (4.9) 118 (9.3) 35 (10.7) 15 (13.2) <0.001
 Hypnotics 504 (8.0) 176 (5.8) 122 (7.9) 134 (10.5) 50 (15.3) 22 (20.3) <0.001
 Anxiolytics 333 (5.4) 110 (3.6) 80 (5.4) 98 (7.9) 27 (8.8) 18 (17.0) <0.001
 Antidepressants 291 (4.8) 107 (3.7) 68 (4.6) 79 (6.4) 21 (6.8) 16 (15.2) <0.001
 Anti-inflammatory medication 442 (7.3) 99 (3.3) 106 (7.1) 144 (11.6) 66 (21.8) 27 (26.3) <0.001
 Cardiovascular medication 2015 (31.3) 861 (27.3) 498 (32.5) 481 (36.8) 128 (38.3) 47 (39.7) <0.001
 Medication for peripheral vascular disorders 645 (10.3) 241 (7.9) 153 (10.2) 183 (14.4) 51 (15.5) 17 (15.1) <0.001
 Medication for skin disorders 429 (6.9) 166 (5.4) 103 (6.7) 109 (8.9) 34 (10.6) 17 (15.9) <0.001
 Insulin agents 429 (6.8) 174 (5.7) 104 (6.9) 106 (8.5) 33 (10.3) 12 (10.9) <0.001
Non-prescribed medication
 Analgesics 603 (9.4) 65 (2.0) 190 (12.3) 233 (17.6) 80 (23.8) 35 (34.3) <0.001
 Gastroesophageal reflux medication 259 (4.1) 74 (2.3) 64 (4.0) 87 (6.8) 24 (7.2) 10 (11.0) <0.001
 Constipation medication 258 (4.0) 84 (2.7) 58 (3.8) 84 (6.3) 25 (7.6) 7 (6.7) <0.001
 Anti-inflammatory medication 166 (2.7) 29 (0.9) 43 (2.8) 60 (4.9) 21 (6.9) 13 (14.9) <0.001
 Medication for skin disorders 315 (5.1) 113 (3.7) 74 (4.8) 84 (7.1) 31 (9.0) 13 (13.8) <0.001
 Asthma medication 214 (3.5) 69 (2.2) 48 (3.2) 68 (5.5) 22 (7.4) 7 (6.4) <0.001
 Vitality supplements 159 (2.7) 57 (2.0) 37 (2.5) 39 (3.2) 21 (7.2) 5 (4.8) <0.001
 Nutritional deficiencies 1342 (21.3) 535(17.5) 334 (22.0) 323 (25.3) 112 (34.6) 38 (34.6) <0.001
 Herbal remedies 305 (5.1) 91 (3.2) 82 (5.5) 91(7.6) 32 (10.2) 9 (9.8) <0.001

Note: Significant p-values are in bold.

Abbreviations: NP, no pain; LP, local pain; RP-Medium, regional pain medium; RP–Heavy, regional pain heavy; WSP, widespread pain; CNS, central nervous system.